Andres Gomez
@GomezDLeonMD
Associate Professor of Hematology @UANL Monterrey, Mexico. Interested in acute leukemia, cell therapy, capacity building in LMICs and writing.
Last month I had the opportunity to visit Hospital Israelita Albert Einstein in Saõ Paulo 🇧🇷 and I was very impressed. Wonderful team, facilities and achievements in the field, especially in #CARTcells… No other like it. Thanks for the invite and tour! @fabiopss…
No todo lo que parece lógico en medicina… funciona en la práctica. 🩸 Validar intervenciones médicas exige más que intuición: requiere ciencia. Por eso los ensayos clínicos aleatorizados siguen siendo el estándar más robusto para evaluar eficacia y seguridad. Desde el diseño…
At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care! Support the @ASH_hematology foundation hematology.org/foundation
📢 ¡Mañana es el ÚLTIMO DÍA para subir y enviar tus Trabajos Libres para el LXVI Congreso Nacional de Hematología 2025! 📄 Consulta la convocatoria completa aquí: 👉 amehac.org/convocatoria-t… #AMEH25 #Hematología #TrabajosLibres #Congreso
🚨 Don’t miss our upcoming webinar on ISBT 128 labeling: implementation steps, challenges, and adoption across LATAM. 📅 July 31 | 🕛 12:00 (UY time) 🔗 Registration required: us06web.zoom.us/meeting/regist… #LABMT #ISBT128 #TransfusionMedicine @TheEBMT @ASTCT @ISBTCO
La trágica muerte del Dr. Abraham Reyes pone -otra vez- en la luz una aberración del sistema de entrenamiento de posgrado: El abuso a los Médicos Residentes. Lean la excelente y dura investigación de @SoleraClaudia en @Milenio. milenio.com/politica/comun…
Research funding? ✅ Expert mentorship? ✅ Networking? ✅ The ASH Global Research Award offers expert mentorship, a global community of investigators, access to resources that help your work go further. Apply: ow.ly/6eEg50Whwao #Hematology #ASHAward
Intermediate-Dose Cytarabine as Postinduction AML Therapy | NEJM Evidence evidence.nejm.org/doi/full/10.10…
📢 Now available online ! Full article : Comparable response rates of venetoclax 50 mg with posaconazole versus venetoclax 400 mg despite lower pharmacokinetic exposure in newly diagnosed acute myeloid leukemia: less is enough 👉tandfonline.com/doi/full/10.10… #asco2025 poster,…
Long awaited results of #VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results for OS. We unfortunately remain in the dreaded boulevard of broken dreams in higher risk #MDSsm. Subgroup analyses will be important. news.abbvie.com/2025-06-16-Abb…
The fact that a consensus recommendation with a significant impact on myeloma care worldwide is behind a paywall is symbolic of how broken academia is and how far removed from any ‘international consensus’ …..just terrible…@VincentRK
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…
Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin #Lymphoma: A Systematic Review. Read the full article. brnw.ch/21wTgyK #ChildhoodCancer
La AMEH te invita a postular al Curso de Investigación Clínica Integral, un taller intensivo de 2 días en Puerto Vallarta, diseñado para fortalecer tus habilidades en investigación con mentoría nacional e internacional. 📍14 y 15 de octubre | Cupo limitado | ✈️ Gastos cubiertos…
A new tool for ITP? Impresive results, just a single case but very provocative. Just 4 doses of Teclistamab.
🌍 Ready to take your research further? Apply for the ASH Global Research Award for funding, mentorship & global connections. New: Explorer Pathway supports applicants from LMICs with added resources. ow.ly/q0jH50VXYcP #Hematology #ASHAwards
New publication🚨 Here we synthethized available evidence on the use of low-doses of nivolumab for r/r HL, an alternative not-so-rarely used in LMICs @PerlaRcp ascopubs.org/doi/pdf/10.120…
🩸 ¡Es tu momento de brillar! ✨ ¡La Convocatoria de Trabajos Libres 2025 ya está abierta! 🎓 🔗 Convocatoria: amehac.org/convocatoria-t… 🗓️ Fecha límite de envío: 14 de julio de 2025. 👉 Importante: Sólo se recibirán trabajos a través de la plataforma. #AMEH25
I am saddened to learn about President Biden’s diagnosis of what seems to be metastatic prostate cancer. However, let’s please get away with the “fighter” metaphor. It’s harmful. This “fight” metaphor leads to excessive and harmful care. And choosing a treatment that prioritizes…
🧵 1/9 📢 Just published! "Advances in the Treatment of AML: Implications for Low- and Middle-Income Countries" 🔓 Open access: mdpi.com/2227-9059/13/5… 🧬 This thread breaks down key insights—and how they can help improve AML care in resource-limited settings.
Surprised by this birthday cake in clinic today… I can’t tell you what I wished for, but let’s hope it comes true before I turn 38🤞🏻#CARTcells Thanks! @rennquevedo
